The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Acetic acid 5-[2-(3,4-dichloro-benzylamino)-6-oxo-1,6-dihydro-purin-7-yl]-pentyl ester ID: ALA361838
PubChem CID: 135524957
Max Phase: Preclinical
Molecular Formula: C19H21Cl2N5O3
Molecular Weight: 438.32
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)OCCCCCn1cnc2nc(NCc3ccc(Cl)c(Cl)c3)nc(O)c21
Standard InChI: InChI=1S/C19H21Cl2N5O3/c1-12(27)29-8-4-2-3-7-26-11-23-17-16(26)18(28)25-19(24-17)22-10-13-5-6-14(20)15(21)9-13/h5-6,9,11H,2-4,7-8,10H2,1H3,(H2,22,24,25,28)
Standard InChI Key: DRTFCWGXCOANMR-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
0.3542 0.4000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3458 -0.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0667 -0.0042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3458 -0.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3542 -1.2417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1792 1.2125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0667 -0.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9625 0.5458 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6333 1.2958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4417 -0.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7917 -1.2417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0708 -1.2417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.8458 1.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8625 -1.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6167 -0.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4000 2.2750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4542 -1.9625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2167 -1.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8542 0.1833 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.5000 -0.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6917 -1.2417 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.6250 -1.9625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0458 1.8458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7708 0.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.0917 0.8833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4958 1.2333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3208 0.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6833 1.4000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1333 0.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 2 0
4 2 2 0
5 7 2 0
6 1 1 0
7 3 1 0
8 2 1 0
9 6 2 0
10 15 2 0
11 7 1 0
12 4 1 0
13 23 1 0
14 17 2 0
15 18 1 0
16 13 2 0
17 22 1 0
18 20 1 0
19 10 1 0
20 11 1 0
21 14 1 0
22 18 2 0
23 26 1 0
24 8 1 0
25 13 1 0
26 28 1 0
27 24 1 0
28 29 1 0
29 27 1 0
9 8 1 0
5 4 1 0
14 10 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 438.32Molecular Weight (Monoisotopic): 437.1021AlogP: 4.18#Rotatable Bonds: 9Polar Surface Area: 102.16Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.33CX Basic pKa: 2.00CX LogP: 4.03CX LogD: 4.03Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.38Np Likeness Score: -1.06
References 1. Wright GE, Brown NC, Xu WC, Long ZY, Zhi C, Gambino JJ, Barnes MH, Butler MM.. (2005) Active site directed inhibitors of replication-specific bacterial DNA polymerases., 15 (3): [PMID:15664846 ] [10.1016/j.bmcl.2004.11.016 ] 2. Xu WC, Wright GE, Brown NC, Long ZY, Zhi CX, Dvoskin S, Gambino JJ, Barnes MH, Butler MM.. (2011) 7-Alkyl-N(2)-substituted-3-deazaguanines. Synthesis, DNA polymerase III inhibition and antibacterial activity., 21 (14): [PMID:21684746 ] [10.1016/j.bmcl.2011.05.093 ]